"Cencora is on pace to do $~250 BILLION in revenue in 2023"

please take us out & put a end to this nonsense- this science needs to be put in the hands of competent people. They can grab rvx while they are at it. Doesn't make sense for a Big Pharma to not grab this now & run with it. At this CEO's rate they will end up with the whole pie for mere Pennie's!! If it's anything like the Eversana deal one can only imagine the debt that zenith will rack up in short order. 
Let it go & let it flow Don , for goodness sake man.